circulating tumor DNA Natera Builds Data Backing Serial ctDNA Changes to Aid CRC Patient Management, Treatment Decisions Premium The company believes its findings are the first to show that quantifying ctDNA changes can stratify high-risk colorectal cancer patients into better and worse prognostic groups. Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy Leaders from collaborating Cleveland Clinic institutes will work with PGDx to optimize its ctDNA test reporting and adapt its technology for new oncology applications. Molecular Health, Eone-Diagnomics Genome Center Ink Liquid Biopsy Partnership EDGC will use Molecular Health's genomics interpretation software to provide circulating tumor DNA sequencing test results for cancer precision medicine. Cell-Free DNA Can Help Predict Pathological Complete Response, Gauge Minimal Residual Disease A suite of new studies examined how liquid biopsies could personalize treatment strategies in a range of cancer types. Blood Testing Distinguishes Benign Tumors From Precancerous Condition Researchers used ultra-low-pass whole genome sequencing and cell-free DNA fragment size selection to detect pre-cancer in neurofibromatosis type 1 patients. Aug 27, 2021 Delfi Diagnostics Tags Lung Cancer as First Target for Fragmentation-Based Liquid Biopsy Tech Premium Aug 5, 2021 Guardant Health Q2 Revenues Grow 39 Percent Aug 3, 2021 TwinStrand Biosciences Sues Guardant Health for Alleged Patent Infringement Jul 29, 2021 Genetron Health Partners with Guizhou Local Government for Liver Cancer Early Screening Project Jul 26, 2021 Foresight Diagnostics Commercializing PhasED-seq Liquid Biopsy Tech for Improved MRD Detection Premium Jul 22, 2021 Natera Minimal Residual Disease Test Predicts Oligometastatic CRC Patient Outcomes in New Study Premium Jun 18, 2021 Natera Aims to Lead Market in Solid Tumor Adjuvant CDx, Supported by New Liquid Biopsy Data Premium Jun 9, 2021 Liquid Biopsy MRD Research at ASCO Showcases Uses in Variety of Tumor Types, Indications Jun 8, 2021 Liquid Biopsy-Guided EGFR Rechallenge Therapy Shows Benefit for Colorectal Cancer Patients Jun 2, 2021 Foresight Diagnostics Raises $12.5M in Series A to Commercialize MRD Detection Tech May 25, 2021 F-Star Therapeutics to Use Inivata's RaDaR Assay in Clinical Studies May 19, 2021 Caris Life Sciences, Fueled by New Funding, Plans to Expand Liquid Biopsy Testing Premium May 19, 2021 Colorectal Cancer Relapse Can Be Predicted by ctDNA Clearance, Study Shows May 18, 2021 Sutter Health Exploring In-House ctDNA Testing in Effort to Expand Precision Oncology Access Premium May 11, 2021 Lucence Launches US Validation Study for Liquid Biopsy in Lung Cancer May 7, 2021 Guardant MRD Test Performs Well in Small Study as Tissue-Informed Debate Takes Shape Premium Apr 28, 2021 NuProbe, AcornMed to Develop Cancer Minimal Residual Disease Detection Products Apr 15, 2021 Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches Premium Apr 15, 2021 OncoDNA, Institut Curie Partner on Liquid Biopsy Research in Head and Neck Cancer Apr 14, 2021 Guardant AACR Data Highlights Value of Clinical Test Database to Drive Drug Resistance Discoveries Load More Breaking News Horse Genetics Study Reveals Origins of Domestication, Use in Human Culture Rady Children's Team Presents Genomic Medicine Management Tool at ASHG Canaccord Genuity Initiates Coverage of Quantum-Si With Buy Rating NIH SenNet Program to Map Rare Senescent Cells Implicated in Human Health Woolly Mammoths Died Out After Climate Shift Eliminated Food Source, Environmental DNA Study Finds Thermo Fisher Scientific Prices $5.85B Senior Notes Offering The Scan Just Breathing A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports. Just Like This One NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna. Slow Start The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000. Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.